Evidence map›Paper›PMID 35190259›Full record

ArticleJournal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy2022

Investigation of the incidence of immunisation stress-related response following COVID-19 vaccination in healthcare workers.

Tomonori Takano, Masanori Hirose, Yukitaka Yamasaki, Masatoshi Hara, Tomoyuki Okada, Hiroyuki Kunishima

Open access · bronzeAbstract read
In one paragraph

Article in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The conundrum of COVID-19 mRNA vaccine-induced anaphylaxis.The journal of allergy and clinical immunology. Global · 2023
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Tomonori TakanoDepartment of Infectious Disease, St. Marianna University School of Medicine, Kanagawa, Japan.
Masanori HiroseDivision of General Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan.
Yukitaka YamasakiDepartment of Infectious Disease, St. Marianna University School of Medicine, Kanagawa, Japan.
Masatoshi HaraDivision of Cardiology and Health Service Centre, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan.
Tomoyuki OkadaDepartment of Otolaryngology and Health Service Centre, St. Marianna University School of Medicine, Kanagawa, Japan.
Hiroyuki KunishimaDepartment of Infectious Disease, St. Marianna University School of Medicine, Kanagawa, Japan. Electronic address: h2kuni@marianna-u.ac.jp.
St. Marianna University School of Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSafe vaccination worldwide is critical to end the coronavirus disease 2019 (COVID-19) pandemic. We aimed to evaluate adverse reactions to vaccination using a web-based questionnaire and examine the risk factors for the occurrence of immunisation stress-related response (ISRR).

methodsWe conducted a questionnaire survey using Google Form® among the employees of St. Marianna University Hospital who had received the COVID-19 vaccine between April 2021 and May 2021, 1 week after the first and second vaccinations. We developed and used a questionnaire to identify individuals with ISRR according to the World Health Organization diagnostic criteria. A generalised linear mixed model was constructed with ISRR onset as the dependent variable, subjects as the random factor, and each parameter as a fixed factor. A multivariate model was constructed using the forced imputation method with factors that were significant in the univariate analysis.

resultsWe enrolled 2,073 and 1,856 respondents in the first and second questionnaire surveys, respectively. Fifty-five and 33 ISRR cases were identified in the first and second vaccinations, respectively. In the univariate analysis, strong pre-vaccination anxiety (odds ratio [OR], 2.3; 95% confidence interval [CI], 1.30-4.12, p = 0·004) and history of allergy (OR, 1.6; 95% CI, 1.14-2.24, p = 0·007) were significant risk factors. Multivariate analysis also showed that strong pre-vaccination anxiety (OR, 2.1; 95% CI, 1.15-3.80, p = 0.016) and history of allergy (OR, 1.5; 95% CI, 1.09-2.15, p = 0.014) were significant risk factors.

conclusionsConfirmation of allergy prior to vaccination and subsequent action are essential for addressing ISRR.

Indexed as

COVID-19HypersensitivityCOVID-19 VaccinesHealth PersonnelHumansIncidenceSARS-CoV-2VaccinationCOVID-19 VaccinesAdverse events following immunisationAllergyAnxiety-related responseCoronavirus disease 2019Immunisation stress-related responseVaccination

Identifiers

PMID35190259
PMCPMC8825314
OpenAlexW4210864513

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.